4 unchanged sentences
001-37581), filed with the SEC on June 24, 2020).
−Removed: Amended and Restated Employment Agreement, dated as of January 12, 2022, by and between the Registrant and Neal Walker (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37581), filed with the SEC on January 14, 2022).
−Removed: Amended and Restated Employment Agreement, dated as of January 12, 2022, by and between the Registrant and Frank Ruffo (incorporated herein by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37581), filed with the SEC on January 14, 2022).
−Removed: Employment Agreement, dated as of January 12, 2022, by and between the Registrant and Joseph Monahan (incorporated herein by reference to Exhibit 10.15 to the Registrant’s Annual Report on Form 10-K (File No.
−Removed: 001-37581), filed with the SEC on February 24, 2022).
−Removed: Employment Agreement, dated as of January 31, 2022, by and between the Registrant and James Loerop (incorporated herein by reference to Exhibit 10.16 to the Registrant’s Annual Report on Form 10-K (File No.
−Removed: 001-37581), filed with the SEC on February 24, 2022).
−Removed: Severance Agreement and General Release, dated as of January 7, 2022, by and between the Registrant and David Gordon (incorporated herein by reference to Exhibit 10.18 to the Registrant’s Annual Report on Form 10-K (File No.
−Removed: 001-37581), filed with the SEC on February 24, 2022).
−Removed: Seventh Amended and Restated Non-Employee Director Compensation Policy (incorporated herein by reference to Exhibit 10.23 to the Registrant’s Annual Report on Form 10-K (File No.
−Removed: 001-37581), filed with the SEC on February 24, 2022).
+Added: Employment Agreement, dated as of June 27, 2022, by and between the Registrant and Gail Cawkwell.
+Added: Employment Agreement, dated as of August 1, 2022, by and between the Registrant and Douglas Manion (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-37581), filed with the SEC on August 1, 2022).
Certification of Principal Executive Officer under Section 302 of the Sarbanes-Oxley Act.
14 unchanged sentences
ACLARIS THERAPEUTICS, INC.
+Added: August 3, 2022
/s/ Neal Walker
−Removed: President and Chief Executive Officer
+Added: Chief Executive Officer
(On behalf of the Registrant)
+Added: August 3, 2022
/s/ Frank Ruffo
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.